APF
CDAK

Alaska Permanent Fund’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Alaska Permanent Fund’s Portfolio CDAK Stock Details CDAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-980,194
Closed -$767K – 421
2022
Q3 		$767K Buy
+980,194
New +$2.06M 0.01% 298
2022
Q2 		– Sell
-980,194
Closed -$6.15M – 449
2022
Q1 		$6.15M Hold
980,194
– – 0.1% 31
2021
Q4 		$6.49M Hold
980,194
– – 0.12% 28
2021
Q3 		$16M Hold
980,194
– – 0.32% 25
2021
Q2 		$18.2M Buy
980,194
+646,861
+194% +$12.4M 0.33% 23
2021
Q1 		$5.03M Hold
333,333
– – 0.09% 42
2020
Q4 		$10.8M Buy
+333,333
New +$4.41M 0.19% 25

Other funds holding CDAK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
LCM
Laurion Capital Management New York $1.07B AUM 75.73% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return